Bausch + Lomb's LuxLife IOL receives CE Mark approval

Bausch + Lomb is expecting LuxLife IOLs to be commercially available in Europe in the coming weeks, with a toric version of the lens to follow. Image credit: AdobeStock/Timon

Bausch + Lomb has announced CE Mark approval for its LuxLife full range of vision intraocular lens (IOL). The preloaded, non-diffractive IOL utilizes Pure Refractive Optics (PRO) technology in order to provide continuous vision for the entire optical diameter and from distance to near, according to a news release.

The company stated in the release that the announcement “reinforces Bausch + Lomb’s commitment to equip cataract surgeons with choices to fit the right lens to the right patient following the recent launches of enVista Envy full range of vision lenses in the United States and Canada and enVista Aspire intermediate-optimized IOLs in Europe.”

“This platform has delivered both quality of vision and patient satisfaction since its introduction,” said Luc Bonnefoy, president of Surgical at Bausch + Lomb, in the release. “LuxLife is an example of how we plan to build on that success by developing premium options designed to meet the evolving needs of surgeons and patients.”

The LuxLife IOL is available in a range of cylinders spanning from +0.75D to +6.00D, which enables surgeons to treat the 79.5% of patients that have more than 0.5D of corneal astigmatism prior to their cataract surgery. Surgeons are also provided options in terms of injection technique during implantation with LuxLife’s preloaded, versatile dual injector system.

A multicentre, comparative clinical study recently evaluated the LuxLife IOL as compared to the monofocal LuxGood IOL and found that patients experienced excellent binocular visual outcomes with LuxLife at near, intermediate, and far distances. The lens also demonstrated high patient satisfaction levels, with 95.6% reporting spectacle independence at intermediate distance and 89.5% at near.

The IOL is also equipped with 2 unique Allied Ray Technology (ART) Zones which can control and refocus light rays. According to the release, the PRO technology and ART Zones allow the lens to maintain light to the retina.

"The LuxLife lens provides truly multifocal optical performance, offering an extensive range of clear vision from distance to near,” said Francisco Javier Castro Alonso, MD, PhD, of UFR-Miguel Servet University Hospital in Zaragoza, Spain, an investigator in the multicentre clinical study, in the release. “I consider this lens a first-choice option for patients seeking freedom from glasses at all distances.”

Bausch + Lomb is expecting LuxLife IOLs to be commercially available in Europe in the coming weeks, with a toric version of the lens to follow. Submissions for regulatory approvals in other countries are currently ongoing.

Reference

1. Bausch + Lomb receives European CE Mark approval for preloaded LuxLife full range of vision intraocular lens. News release. May 7, 2025. Accessed May 8, 2025. https://www.bausch.com/newsroom/news/?id=260